To the Editors: Recently, Baftiu et al. published a very nice and important paper entitled: “Availability of antiepileptic drugs across Europe.” In their study, they observed that the main reasons for poor access to antiepileptic drugs (AEDs) in European countries were lack of regulatory approval, high prices, and reimbursement restrictions. There were large gaps in AED availability across Euro...